Home › Funds › Checkpoint Capital L.P. › TRVI
Checkpoint Capital L.P. position in TRVI
TREVI THERAPEUTICS INC · Health Care
Checkpoint Capital L.P. reported holding 137,000 shares of TRVI (TREVI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.44% of its reported portfolio and ranking #7 among its reported holdings. Checkpoint Capital L.P. has disclosed TRVI holdings in 8 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Checkpoint Capital L.P.'s TRVI position evolved
Checkpoint Capital L.P. first disclosed a stake in TRVI in Q4 2023 at 1,292,316 shares (US$1.7M). The position peaked in Q4 2024 at 1,084,135 shares, worth US$4.5M. Across 8 filings, Checkpoint Capital L.P. increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 137,000 shares valued at US$2.0M — an increase of 62,000 shares quarter over quarter.. Notable position changes include a 61% trim in Q1 2024 (shares fell 14% over the following quarter), a 334% increase in Q4 2024 (shares rose 53% over the following quarter), a 83% increase in Q3 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.29M | $1.73M | New |
| Q1 2024 | 506.08K | $1.75M | Reduce |
| Q2 2024 | 500.09K | $1.49M | Reduce |
| Q3 2024 | 250.00K | $835.00K | Reduce |
| Q4 2024 | 1.08M | $4.47M | Add |
| Q1 2026 | 50.00K | $596.50K | New |
| Q2 2026 | 75.00K | $1.40M | Add |
| Q3 2026 | 137.00K | $1.96M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TRVI and 13F data
TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 61 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$60.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TRVI
- NEA Management Company, LLC 13.22M sh · $246.59M · Q2 2026
- Frazier Life Sciences Management, L.P. 9.94M sh · $185.37M · Q2 2026
- Vivo Capital, LLC 4.23M sh · $60.57M · Q3 2026
- Vestal Point Capital, LP 3.10M sh · $57.81M · Q2 2026
- MPM BioImpact LLC 3.07M sh · $57.32M · Q2 2026
- Artia Global Partners LP 2.21M sh · $41.23M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 2.14M sh · $40.00M · Q2 2026
- First Light Asset Management, LLC 2.10M sh · $39.11M · Q2 2026
- Logos Global Management LP 1.88M sh · $35.06M · Q2 2026
- ORBIMED ADVISORS LLC 1.43M sh · $26.67M · Q2 2026
- Affinity Asset Advisors, LLC 1.80M sh · $25.78M · Q3 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.74M sh · $24.96M · Q3 2026
More on Checkpoint Capital L.P.
FAQ
How long has Checkpoint Capital L.P. held TRVI?
Checkpoint Capital L.P. has disclosed TRVI holdings in 8 of the last 12 reported quarters, going back to Q4 2023.
What is Checkpoint Capital L.P.'s current position in TRVI?
As of Q3 2026, Checkpoint Capital L.P. holds 137.00K shares of TRVI (TREVI THERAPEUTICS INC), valued at $1.96M, representing 0.44% of its reported portfolio and ranking #7.
Has Checkpoint Capital L.P. been buying or selling TRVI?
In the latest 13F filing (Q3 2026), Checkpoint Capital L.P. increased its position in TRVI. The position peaked in Q4 2024 at 1.08M shares.
Which other funds hold TRVI?
Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.